abstract |
An object of the present invention is to provide a novel ascochlorine derivative that activates adenosine monophosphate activated protein kinase (AMPK), and is useful in the treatment or prevention of diseases or conditions that involve the deregulation of AMPK; The present invention provides a compound presented by formula I, a pharmaceutically acceptable solvate thereof. |